Method for treating cancer based on metallofullerene monocrystalline nanoparticles that specifically disrupt tumor blood vessels
AssigneeBeijing Fullcan Bio-technology Co., Ltd.
InventorsChunru WANG, Mingming ZHEN, Chunying SHU, Taishan WANG, Jie LI, Guoqiang ZHANG
Life of this patent
Estimating the term…